S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Prima BioMed First Quarter Report, Management Conference Call and CVac Program Update (2013/10/31)|
|Expert Panel to Discuss Prima BioMed's CVac Clinical Trial Data in Ovarian Cancer (2013/11/25)|
|Prima BioMed to Present at the 15th Annual Rodman & Renshaw Global Investment Conference ()|
|Prima BioMed's "CANVAS" Clinical Trial Approved to Start in Korea ()|
|Prima BioMed Management Presentation of CVAC(TM) Phase 2 Trial Results (2013/9/30)|
|Prima BioMed to Present at WDM Capital 1st Global Life Sciences Conference in Warsaw (2013/9/11)|
|Prima BioMed's CEO to Present at 11th Annual Commercial Translation of Regenerative Medicine Meeting (2013/11/19)|
|Top-Line Analysis of CVac(TM) Phase 2 Trial; Ovarian Cancer Clinical Development Update (2013/9/18)|
|CVac(TM) CAN-003 Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer Annual Meeting (2013/9/3)|
Click above to view more mutual fund data and stats for pbmd - Prima Biomed Ltd. ADR.